Disturbance of deposition and removal of plutonium

The chelation therapy using DTPA (diethylenetriaminepentaacetic acid) and a new drug, CBMIDA [catechol 3, 6-bis (methyleiminodiacetic acid)] showing more effectiveness on removal of plutonium and lower toxicity than DTPA, is available for occupational exposure but is difficult for public exposure, because there are many reluctant problems on their toxicities, administration routes and times, physical conditions of victims etc. We demonstrated that active amino acid calcium (AAACa), a natural product which mixed oyster shell electrolysate and amino acids of seaweeds, could remove plutonium from bone and liver in rats. The removing methods of radionuclides using the bioavailability of AAACa will be utilized for public exposures and resolve the reluctant problems accompanied with a chelation therapy for occupational exposure. (author)